NASDAQ : AMRX
Amneal Pharmaceuticals, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 21.51 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 7.49B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Amneal Pharmaceuticals, Inc. (AMRX) reported revenue of 3.12B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 3.12B | 3.02B | 2.79B | 2.39B | 2.21B | 2.09B |
| Cost of Revenue | 1.88B | 1.89B | 1.78B | 1.54B | 1.42B | 1.31B |
| Gross Profit | 1.24B | 1.13B | 1.02B | 852.87M | 791.46M | 783.95M |
| Selling, General & Admin | 571.88M | 526.85M | 476.54M | 429.77M | 399.70M | 365.50M |
| Research & Development | 175.55M | 186.15M | 190.61M | 163.85M | 195.69M | 201.85M |
| Other Operating Expenses | -1.48M | -5.24M | -1.14M | -3.96M | ||
| Operating Expenses | 745.95M | 707.76M | 667.15M | 592.49M | 591.43M | 567.35M |
| Operating Income | 495.15M | 420.70M | 348.36M | 260.38M | 200.03M | 216.60M |
| Interest Expense | -227.46M | -241.09M | -258.60M | -210.63M | -158.38M | -136.32M |
| Currency Exchange Gain (Loss) | -14.62M | 7.63M | -6.85M | 1.67M | -12.36M | -355.00K |
| Other Non Operating Income (Expenses) | 24.21M | 9.93M | -42.66M | 5.12M | 17.83M | 15.33M |
| EBT Excluding Unusual Items | 277.28M | 197.18M | 40.26M | 56.54M | 47.12M | 95.25M |
| Merger & Restructuring Charges | -16.57M | -4.21M | -2.35M | -1.75M | -2.13M | -9.91M |
| Gain (Loss) on Sale of Assets | 3.76M | |||||
| Asset Writedown | -22.78M | -22.78M | -920.00K | -36.13M | -11.11M | -22.69M |
| Legal Settlements | -8.75M | 390.00K | -96.69M | -1.82M | -269.93M | -25.00M |
| Other Unusual Items | -28.00M | -31.36M | 930.00K | -26.31M | -1.02M | -10.57M |
| Pretax Income | 201.18M | 139.21M | -55.01M | -40.27M | -248.13M | 31.37M |
| Income Tax Expense | -14.14M | 11.28M | 18.86M | 8.45M | 6.66M | 11.20M |
| Earnings From Continuing Operations | 215.32M | 127.93M | -73.88M | -48.72M | -254.79M | 20.17M |
| Minority Interest in Earnings | -57.96M | -55.88M | -43.01M | -35.27M | 124.80M | -9.55M |
| Net Income | 157.36M | 72.06M | -116.89M | -83.99M | -129.99M | 10.62M |
| Net Income to Common | 157.36M | 72.06M | -116.89M | -83.99M | -129.99M | 10.62M |
| Shares Outstanding (Basic) | 315.98M | 313.37M | 308.98M | 176.14M | 150.94M | 148.92M |
| Shares Outstanding (Diluted) | 327.48M | 324.81M | 308.98M | 176.14M | 150.94M | 151.82M |
| EPS (Basic) | 0.50 | 0.23 | -0.38 | -0.48 | -0.86 | 0.07 |
| EPS (Diluted) | 0.48 | 0.22 | -0.38 | -0.48 | -0.86 | 0.07 |
| Free Cash Flow | 83.11M | 241.15M | 234.76M | 298.78M | 16.30M | 190.88M |
| Free Cash Flow Per Share | 0.25 | 0.74 | 0.76 | 1.70 | 0.11 | 1.26 |
| Gross Margin | 39.81% | 37.38% | 36.35% | 35.63% | 35.77% | 37.44% |
| Operating Margin | 15.88% | 13.94% | 12.47% | 10.88% | 9.04% | 10.35% |
| Profit Margin | 5.05% | 2.39% | -4.18% | -3.51% | -5.88% | 0.51% |
| Free Cash Flow Margin | 2.67% | 7.99% | 8.40% | 12.48% | 0.74% | 9.12% |
| EBITDA | 689.44M | 644.27M | 584.55M | 489.78M | 440.21M | 450.00M |
| EBITDA Margin | 22.12% | 21.34% | 20.92% | 20.46% | 19.90% | 21.49% |
| D&A For EBITDA | 194.29M | 223.57M | 236.19M | 229.40M | 240.18M | 233.41M |
| EBIT | 495.15M | 420.70M | 348.36M | 260.38M | 200.03M | 216.60M |
| EBIT Margin | 15.88% | 13.94% | 12.47% | 10.88% | 9.04% | 10.35% |
| Effective Tax Rate | 8.10% | 35.70% | ||||
| Advertising Expenses | 42.00M | 34.40M | 12.40M | 16.80M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 127.64M | 282.03M | 110.55M | 91.54M | 25.98M | 247.79M |
| Short-Term Investments | 3.78M | 4.44M | 1.87M | 2.20M | 1.82M | 1.17M |
| Cash & Short-Term Investments | 131.41M | 286.47M | 112.42M | 93.74M | 27.80M | 248.96M |
| Accounts Receivable | 1.02B | 895.14M | 775.73M | 613.73M | 741.79M | 662.58M |
| Other Receivables | 62.27M | 44.73M | 32.83M | 31.93M | 54.62M | 32.06M |
| Receivables | 1.08B | 939.87M | 808.56M | 645.66M | 796.41M | 694.64M |
| Inventory | 677.95M | 606.30M | 612.45M | 581.38M | 530.74M | 489.39M |
| Prepaid Expenses | 46.39M | 49.70M | 46.50M | 49.51M | 47.12M | 45.07M |
| Restricted Cash | 8.64M | 28.84M | 7.87M | 7.57M | 9.25M | 8.95M |
| Other Current Assets | 500.00K | 33.10M | ||||
| Total Current Assets | 1.95B | 1.91B | 1.59B | 1.38B | 1.41B | 1.52B |
| Property, Plant & Equipment | 567.32M | 550.33M | 523.69M | 550.14M | 589.36M | 639.00M |
| Long-Term Investments | 16.21M | 5.76M | 35.92M | 37.09M | 85.59M | |
| Goodwill | 593.50M | 595.47M | 597.44M | 598.63M | 598.85M | 593.02M |
| Other Intangible Assets | 587.83M | 563.50M | 732.38M | 890.42M | 1.10B | 1.17B |
| Long-Term Deferred Charges | 4.62M | 5.20M | 2.82M | 4.43M | 2.21M | 1.60M |
| Other Long-Term Assets | 59.84M | 46.85M | 21.39M | 14.00M | 15.43M | 19.01M |
| Total Assets | 3.78B | 3.68B | 3.50B | 3.47B | 3.80B | 3.94B |
| Accounts Payable | 244.48M | 254.93M | 259.84M | 145.53M | 166.84M | 132.87M |
| Accrued Expenses | 290.03M | 328.59M | 317.53M | 246.01M | 218.21M | 220.57M |
| Short-Term Debt | 100.00M | 100.00M | 179.00M | 60.00M | ||
| Current Portion of Long-Term Debt | 5.96M | 6.76M | 224.21M | 34.12M | 29.96M | 30.61M |
| Current Portion of Leases | 15.46M | 14.81M | 16.04M | 14.50M | 14.68M | 15.42M |
| Current Income Taxes Payable | 2.52M | |||||
| Other Current Liabilities | 227.25M | 276.54M | 212.14M | 227.43M | 263.11M | 275.24M |
| Total Current Liabilities | 883.19M | 881.63M | 1.13B | 846.60M | 752.80M | 677.24M |
| Long-Term Debt | 2.56B | 2.57B | 2.16B | 2.43B | 2.63B | 2.73B |
| Long-Term Leases | 106.00M | 102.36M | 91.09M | 95.45M | 108.81M | 111.93M |
| Other Long-Term Liabilities | 105.84M | 123.21M | 163.33M | 41.77M | 97.12M | 37.05M |
| Total Liabilities | 3.66B | 3.67B | 3.55B | 3.41B | 3.59B | 3.56B |
| Common Stock | 3.19M | 3.15M | 3.10M | 3.07M | 3.04M | 3.01M |
| Additional Paid-In Capital | 545.58M | 571.79M | 560.21M | 539.24M | 691.63M | 658.35M |
| Retained Earnings | -415.09M | -535.00M | -607.06M | -490.18M | -406.18M | -276.20M |
| Comprehensive Income & Other | -100.67M | -110.73M | -65.51M | -32.35M | 9.94M | -24.83M |
| Total Common Equity | 33.02M | -70.79M | -109.27M | 19.78M | 298.42M | 360.34M |
| Minority Interest | 83.96M | 76.76M | 64.73M | 41.52M | -89.49M | 23.54M |
| Shareholders' Equity | 116.98M | 5.96M | -44.54M | 61.30M | 208.93M | 383.88M |
| Total Liabilities & Equity | 3.78B | 3.68B | 3.50B | 3.47B | 3.80B | 3.94B |
| Total Debt | 2.79B | 2.69B | 2.59B | 2.75B | 2.85B | 2.89B |
| Net Cash (Debt) | -2.66B | -2.40B | -2.48B | -2.66B | -2.82B | -2.64B |
| Net Cash Per Share | -8.12 | -7.40 | -8.03 | -15.08 | -18.66 | -17.38 |
| Filing Date Shares Outstanding | 319.35M | 314.63M | 309.97M | 307.01M | 151.50M | 149.42M |
| Total Common Shares Outstanding | 319.33M | 314.56M | 309.88M | 306.56M | 151.49M | 149.41M |
| Working Capital | 1.06B | 1.03B | 458.04M | 531.27M | 659.02M | 842.87M |
| Book Value Per Share | 0.10 | -0.23 | -0.35 | 0.06 | 1.97 | 2.41 |
| Tangible Book Value | -1.15B | -1.23B | -1.44B | -1.47B | -1.40B | -1.40B |
| Tangible Book Value Per Share | -3.60 | -3.91 | -4.64 | -4.79 | -9.22 | -9.37 |
| Land | 19.69M | 8.11M | 9.02M | 10.71M | 11.54M | |
| Buildings | 234.60M | 224.66M | 227.84M | 225.63M | 230.99M | |
| Machinery | 568.09M | 546.56M | 524.61M | 485.44M | 484.42M | |
| Construction In Progress | 92.91M | 78.20M | 67.67M | 69.34M | 58.26M | |
| Leasehold Improvements | 133.83M | 130.91M | 126.46M | 124.67M | 123.51M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 157.36M | 72.06M | -116.89M | -83.99M | -129.99M | 10.62M |
| Depreciation & Amortization | 194.29M | 223.57M | 236.19M | 229.40M | 240.18M | 233.41M |
| Other Amortization | 16.70M | 22.43M | 29.10M | 11.55M | 8.60M | 9.20M |
| Asset Writedown & Restructuring Costs | 22.78M | 22.78M | 920.00K | 66.93M | 24.08M | 28.55M |
| Stock-Based Compensation | 35.63M | 31.95M | 27.77M | 26.82M | 31.85M | 28.41M |
| Other Operating Activities | 218.63M | 171.71M | 122.08M | 142.05M | -49.67M | 65.21M |
| Change in Accounts Receivable | -213.72M | -120.57M | -162.64M | 126.29M | -79.72M | -23.62M |
| Change in Inventory | -175.14M | -87.03M | -130.53M | -126.18M | -102.40M | -49.02M |
| Change in Accounts Payable | 30.41M | 21.32M | 235.13M | -94.45M | 109.57M | -43.93M |
| Change in Other Net Operating Assets | -86.17M | -18.25M | 53.96M | 47.15M | 12.60M | -17.02M |
| Operating Cash Flow | 200.78M | 339.99M | 295.10M | 345.58M | 65.10M | 241.82M |
| Capital Expenditures | -117.67M | -98.84M | -60.34M | -46.80M | -48.80M | -50.94M |
| Sale of Property, Plant & Equipment | 715.00K | 2.09M | ||||
| Cash Acquisitions | -84.71M | -146.54M | ||||
| Divestitures | 11.99M | |||||
| Sale (Purchase) of Intangibles | -95.41M | -15.51M | -14.65M | -22.39M | -41.80M | -1.70M |
| Other Investing Activities | 1.00M | 5.00M | ||||
| Investing Cash Flow | -212.37M | -112.26M | -63.00M | -69.19M | -174.31M | -194.18M |
| Short-Term Debt Issued | 218.00M | 48.00M | 219.00M | 85.00M | ||
| Long-Term Debt Issued | 2.70B | 217.73M | ||||
| Total Debt Issued | 2.94B | 2.92B | 48.00M | 436.73M | 85.00M | |
| Short-Term Debt Repaid | -1.00M | |||||
| Long-Term Debt Repaid | -2.81B | -233.12M | -414.08M | -123.27M | -78.18M | |
| Total Debt Repaid | -2.71B | -2.81B | -233.12M | -414.08M | -123.27M | -79.18M |
| Net Debt Issued (Repaid) | 228.33M | 107.61M | -185.12M | 22.65M | -38.27M | -79.18M |
| Issuance of Common Stock | 1.29M | 1.96M | 1.15M | 451.00K | 662.00K | 853.00K |
| Repurchase of Common Stock | -44.93M | -22.28M | -7.95M | -2.38M | -3.57M | -2.66M |
| Other Financing Activities | -115.06M | -118.82M | -19.88M | -233.30M | -65.44M | -57.13M |
| Financing Cash Flow | 69.63M | -31.53M | -211.79M | -212.57M | -106.62M | -138.12M |
| Foreign Exchange Rate Adjustments | -2.09M | -1.68M | -999.00K | 65.00K | -5.68M | 102.00K |
| Net Cash Flow | 55.95M | 194.52M | 19.31M | 63.88M | -221.51M | -90.38M |
| Free Cash Flow | 83.11M | 241.15M | 234.76M | 298.78M | 16.30M | 190.88M |
| Free Cash Flow Margin | 2.67% | 7.99% | 8.40% | 12.48% | 0.74% | 9.12% |
| Free Cash Flow Per Share | 0.25 | 0.74 | 0.76 | 1.70 | 0.11 | 1.26 |
| Levered Free Cash Flow | -115.33M | 197.07M | 253.45M | 300.39M | 120.14M | 217.65M |
| Unlevered Free Cash Flow | 10.13M | 325.32M | 385.98M | 420.48M | 210.53M | 293.65M |
| Cash Interest Paid | 176.95M | 197.85M | 263.52M | 192.81M | 142.72M | 121.75M |
| Cash Income Tax Paid | 8.45M | 21.33M | 15.22M | 2.50M | 12.65M | 15.56M |
| Change in Working Capital | -444.62M | -204.52M | -4.07M | -47.19M | -59.95M | -133.59M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 7.49B | 3.96B | 2.45B | 1.86B | 301.44M | 715.49M |
| Enterprise Value | 10.15B | 6.51B | 5.08B | 4.43B | 2.99B | 3.37B |
| Last Close Price | 21.51 | 12.60 | 7.92 | 6.07 | 1.99 | 4.79 |
| PE Ratio | 44.74 | 54.97 | 67.35 | |||
| Forward PE | 21.34 | 15.04 | 11.69 | 11.92 | 2.71 | 5.65 |
| PS Ratio | 2.40 | 1.31 | 0.88 | 0.78 | 0.14 | 0.34 |
| PB Ratio | 207.99 | 664.26 | -55.10 | 30.35 | 1.44 | 1.86 |
| P/FCF Ratio | 90.15 | 16.43 | 10.45 | 6.23 | 18.49 | 3.75 |
| P/OCF Ratio | 37.31 | 11.65 | 8.32 | 5.38 | 4.63 | 2.96 |
| PEG Ratio | 2.37 | 0.51 | 0.51 | 0.51 | 0.18 | 0.66 |
| EV/Sales Ratio | 3.26 | 2.16 | 1.82 | 1.85 | 1.35 | 1.61 |
| EV/EBITDA Ratio | 14.73 | 10.11 | 8.69 | 9.05 | 6.79 | 7.49 |
| EV/EBIT Ratio | 20.50 | 15.47 | 14.59 | 17.03 | 14.94 | 15.57 |
| EV/FCF Ratio | 122.16 | 27.00 | 21.64 | 14.84 | 183.29 | 17.67 |
| Debt / Equity Ratio | 23.86 | 450.95 | -58.22 | 44.87 | 13.62 | 7.52 |
| Debt / EBITDA Ratio | 3.94 | 4.06 | 4.31 | 5.43 | 6.15 | 6.15 |
| Debt / FCF Ratio | 33.59 | 11.15 | 11.05 | 9.21 | 174.50 | 15.13 |
| Net Debt / Equity Ratio | 22.74 | 402.92 | -55.70 | 43.34 | 13.48 | 6.87 |
| Net Debt / EBITDA Ratio | 3.86 | 3.73 | 4.24 | 5.42 | 6.40 | 5.86 |
| Net Debt / FCF Ratio | 32.01 | 9.96 | 10.57 | 8.89 | 172.79 | 13.82 |
| Asset Turnover | 0.87 | 0.84 | 0.80 | 0.66 | 0.57 | 0.53 |
| Inventory Turnover | 2.92 | 3.10 | 2.98 | 2.77 | 2.79 | 2.67 |
| Quick Ratio | 1.38 | 1.39 | 0.81 | 0.87 | 1.09 | 1.39 |
| Current Ratio | 2.21 | 2.17 | 1.41 | 1.63 | 1.88 | 2.25 |
| Return on Equity (ROE) | 613.02% | -881.26% | -36.06% | -85.96% | 5.45% | |
| Return on Assets (ROA) | 8.60% | 7.32% | 6.24% | 4.48% | 3.23% | 3.41% |
| Return on Invested Capital (ROIC) | 18.64% | 16.18% | 13.69% | 9.07% | 6.61% | 4.62% |
| Return on Capital Employed (ROCE) | 17.10% | 15.00% | 14.70% | 9.90% | 6.60% | 6.60% |
| Earnings Yield | 2.24% | 1.82% | -4.76% | -4.51% | -43.12% | 1.49% |
| FCF Yield | 1.11% | 6.09% | 9.57% | 16.06% | 5.41% | 26.68% |
| Buyback Yield / Dilution | -3.48% | -5.12% | -75.42% | -16.69% | 0.58% | -1.95% |
| Total Shareholder Return | -3.48% | -5.12% | -75.42% | -16.69% | 0.58% | -1.95% |